AIC
AZN icon

Archer Investment Corporation’s AstraZeneca AZN Stock Holding History

Archer Investment Corporation’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51K Hold
269
– – 0.01% 519
2026
Q1 		$53K Hold
269
– – 0.01% 516
2025
Q4 		$49.5K Hold
269
– – 0.01% 476
2025
Q3 		$41.3K Buy
269
+1
+0.4% +$151 0.01% 506
2025
Q2 		$37.5K Hold
268
– – 0.01% 513
2025
Q1 		$39.4K Buy
268
+30
+13% +$4.34K 0.01% 491
2024
Q4 		$31.2K Hold
238
– – 0.01% 511
2024
Q3 		$37.1K Buy
238
+1
+0.4% +$161 0.01% 480
2024
Q2 		$37K Hold
237
– – 0.01% 462
2024
Q1 		$32.1K Hold
237
– – 0.01% 466
2023
Q4 		$31.9K Hold
237
– – 0.01% 463
2023
Q3 		$32.1K Hold
237
– – 0.01% 442
2023
Q2 		$33.9K Buy
237
+137
+137% +$20.2K 0.01% 432
2023
Q1 		$13.9K Hold
100
– – 0.01% 529
2022
Q4 		$13.6K Hold
100
– – 0.01% 511
2022
Q3 		$11K Hold
100
– – ﹤0.01% 515
2022
Q2 		$13.2K Hold
100
– – 0.01% 508
2022
Q1 		$14.1K Hold
100
– – 0.01% 509
2021
Q4 		$11.7K Hold
100
– – ﹤0.01% 534
2021
Q3 		$12K Hold
100
– – ﹤0.01% 508
2021
Q2 		$12K Hold
100
– – ﹤0.01% 442
2021
Q1 		$9.94K Hold
100
– – ﹤0.01% 544
2020
Q4 		$10K Hold
100
– – ﹤0.01% 499
2020
Q3 		$11K Hold
100
– – 0.01% 440
2020
Q2 		$10.6K Sell
100
-15
-13% -$1.55K 0.01% 423
2020
Q1 		$10K Hold
115
– – 0.01% 412
2019
Q4 		$11K Buy
115
+100
+667% +$9.41K 0.01% 439
2019
Q3 		$1K Hold
15
– – ﹤0.01% 467
2019
Q2 		$1K Hold
15
– – ﹤0.01% 456
2019
Q1 		$1K Hold
15
– – ﹤0.01% 466
2018
Q4 		$1K Buy
+15
New +$1.17K ﹤0.01% 433

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Archer Investment Corporation's AZN Position: Q2 2026 in Review

Archer Investment Corporation held its AstraZeneca (AZN) position steady in Q2 2026 at 269 shares worth $51K. The position accounts for 0.01% of the portfolio, ranked #519.

Archer Investment Corporation first reported a position in AZN in Q4 2018 and has held it in 31 quarters since. The position peaked at $53K in Q1 2026. 1,149 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Archer Investment Corporation held 269 shares of AstraZeneca worth $51K as of Q2 2026.
  • Archer Investment Corporation left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #519 holding.
  • Archer Investment Corporation first reported a position in AstraZeneca in Q4 2018 and has held it in 31 quarters since.
  • Archer Investment Corporation's AstraZeneca position peaked at $53K in Q1 2026.
  • 1,149 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.